Copyright
©2013 Baishideng Publishing Group Co.
World J Crit Care Med. Nov 4, 2013; 2(4): 48-55
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Figure 5 Survival curves.
Survival curves of the bevacizumab-treated (n = 5), and untreated mice (n = 5). The mean survival duration of the treated mice was 30.8 d and of the untreated mice was 23.6 d (P = 0.005).
- Citation: Aoyagi K, Kouhuji K, Miyagi M, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer. World J Crit Care Med 2013; 2(4): 48-55
- URL: https://www.wjgnet.com/2220-3141/full/v2/i4/48.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v2.i4.48